Xenetic Biosciences, Inc. (OTCBB:XBIO), a biopharmaceutical company focused on developing next-generation biologic drugs and novel oncology therapeutics, announces that CEO M. Scott Maguire has written a Letter to Shareholders, the full text of which appears below:
To Our Shareholders:
The year 2014 at Xenetic Biosciences has been defined by a number of significant achievements. As I review all the activities of the past year I am, quite frankly, extremely excited and proud to share with you our considerable accomplishments and to review our plans to build upon that momentum in 2015. Key highlights of 2014 included:
Help employers find you! Check out all the jobs and post your resume.
